TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $3

TD Cowen analyst Ryan Langston has maintained a 'Hold' rating on P3 Health Partners (NASDAQ: PIII) and has reduced the price target from $8 to $3. This adjustment reflects a change in the analyst's outlook on the company's stock performance.